How to buy Privia Health Group (PRVA) stock

Privia Health Group, Inc is a health information services business based in the US. Privia Health Group shares (PRVA) are listed on the NASDAQ and all prices are listed in US Dollars. Privia Health Group employs 559 staff and has a trailing 12-month revenue of around 0.00.

Privia Health Group stock price (NASDAQ: PRVA)

Use our graph to track the performance of PRVA stocks over time.

Privia Health Group shares at a glance

• Key figures

Information last updated 2021-07-09.

52-week range	$27.15 - $50.77
50-day moving average	$39.95
200-day moving average	$37.32
Wall St. target price	$43.40
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Privia Health Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Privia Health Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Privia Health Group, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Privia Health Group under- or over-valued?

Valuing Privia Health Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Privia Health Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Privia Health Group's EBITDA

Privia Health Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $28.7 million.

The EBITDA is a measure of a Privia Health Group's overall financial performance and is widely used to measure a its profitability.

To put Privia Health Group's EBITDA into context you can compare it against that of similar companies.

• Evolent Health (EVH.US): USD$7.6 million

Privia Health Group financials

Revenue TTM	$817.7 million
Operating margin TTM	3.28%
Gross profit TTM	$82.6 million
Return on assets TTM	5.3%
Return on equity TTM	24.61%
Profit margin	3.82%
Book value	N/A
Market capitalisation	$4.5 billion

TTM: trailing 12 months

Shorting Privia Health Group shares

There are currently 1.3 million Privia Health Group shares held short by investors – that's known as Privia Health Group's "short interest". This figure is 35.1% up from 948,495 last month.

There are a few different ways that this level of interest in shorting Privia Health Group shares can be evaluated.

Privia Health Group's "short interest ratio" (SIR)

Privia Health Group's "short interest ratio" (SIR) is the quantity of Privia Health Group shares currently shorted divided by the average quantity of Privia Health Group shares traded daily (recently around 451039.43661972). Privia Health Group's SIR currently stands at 2.84. In other words for every 100,000 Privia Health Group shares traded daily on the market, roughly 2840 shares are currently held short.

To gain some more context, you can compare Privia Health Group's short interest ratio against those of similar companies.

• Evolent Health (EVH.US): 17.53
• Oak Street Health (OSH.US): 5.28
• 1Life Healthcare (ONEM.US): 9.49

However Privia Health Group's short interest can also be evaluated against the total number of Privia Health Group shares, or, against the total number of tradable Privia Health Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Privia Health Group's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Privia Health Group shares in existence, roughly 10 shares are currently held short) or 0.0493% of the tradable shares (for every 100,000 tradable Privia Health Group shares, roughly 49 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Privia Health Group.

Find out more about how you can short Privia Health Group stock.

Privia Health Group share dividends

We're not expecting Privia Health Group to pay a dividend over the next 12 months.

Privia Health Group overview

Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.

Frequently asked questions

What percentage of Privia Health Group is owned by insiders or institutions?
Currently 75.031% of Privia Health Group shares are held by insiders and 5.261% by institutions. How many people work for Privia Health Group?
Latest data suggests 559 work at Privia Health Group. When does the fiscal year end for Privia Health Group?
Privia Health Group's fiscal year ends in December. Where is Privia Health Group based?
Privia Health Group's address is: 950 North Glebe Road, Arlington, VA, United States, 22203